NCT06273306View on ClinicalTrials.gov

Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model (IMIDOC)

NANot yet recruitingINTERVENTIONAL

Enrollment

360

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2026

Conditions

TelemedicineTelehealtheHealthRheumatic DiseasesArthritis, RheumatoidSpondylarthritis

Interventions

DEVICE

IMIDOC

Patient´s Mobile App for recording clinical data

All Listed Sponsors

lead

Instituto de Investigación Hospital Universitario La Paz

OTHER

NCT06273306 - Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model (IMIDOC) | Biotech Hunter | Biotech Hunter